35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

35Pharma

35Pharma | 2,353 followers on LinkedIn. Clinical-stage biopharmaceutical company that designs and develops TGF-beta superfamily therapeutics | 35Pharma is a clinical-stage biopharmaceutical company specializing in TGF-beta superfamily therapeutics for the treatment of Cardiometabolic Disease and Obesity. 35Pharma leverages its scientific leadership in TGF-beta biology combined with superior protein engineering to discover innovative compounds that selectively and potently neutralize validated pathological TGF-beta ligands while sparing beneficial homeostatic ligands.

We believe in connecting rigorous science with our innate sense of urgency to rapidly generate breakthrough therapies for patients in need of a better quality of life.

Our beautiful R&amp;D and office facilities are located in the heart of Montreal, Canada, where a diverse team of industry professionals work together to execute on our mission to serve patients in need.

Chief Executive Officer at 35Pharma

Ilia A. Tikhomirov

Biotech Business & Corporate Development executive, IR, PR - passionate about translating science into medicines｜PhD, MBA

Julia Schoelermann

Managing Partner at venBio Partners

Aaron Royston, M.D.

Clinical Research and Development Executive

Monique Champagne

Travelling to ObesityWeek in San Antonio? Join our CSO Maureen O’Connor as she shares exciting pre-clinical data with our novel Activin and GDF inhibitor HS235 in obese HFpEF on Monday, Nov 3rd at 8:30am! Check out the whole press release here: https://lnkd.in/etFwegGu #ObesityWeek #Biotech #heartfailure #obesity #cardiometabolic

We're #hiring a new Senior Clinical Research Associate / Line Manager in Montreal, Quebec. Apply today or share this post with your network.

Joignez-vous à l'équipe! | Join our team! https://lnkd.in/eYXhnJtN

Joignez-vous à l'équipe! https://lnkd.in/enwC33RH

35Pharma Announces Participation at Upcoming Investor Conferences https://lnkd.in/ee6PYaMk

Une excellente #opportunité ! Veuillez le consulter ou le partager avec un collègue...

Rejoindre notre équipe #incroyable aujourd'hui!

Rejoindre notre équipe #incroyable ! Join our #dynamic team!

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 7:37 PM	90301dcc
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 7:37 PM	5178bef7
crunchbase trigger	general	Nov 12, 2024 7:37 PM	3347799b
crunchbase profile	general
li profile	general	Nov 12, 2024 7:37 PM	c2f21442
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 7:37 PM	3df4eb41
news basic	general	Nov 12, 2024 7:37 PM	7e2a5927
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

35PH

COM:35PHARMA

35Pharma